|Publication number||US3870042 A|
|Publication date||Mar 11, 1975|
|Filing date||Oct 6, 1972|
|Priority date||Oct 13, 1971|
|Also published as||CA1018417A, CA1018417A1, DE2248265A1|
|Publication number||US 3870042 A, US 3870042A, US-A-3870042, US3870042 A, US3870042A|
|Inventors||Leon Fernand Viguier|
|Original Assignee||Lab Medicoplast|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (7), Referenced by (46), Classifications (13)|
|External Links: USPTO, USPTO Assignment, Espacenet|
United States Patent 1191 Viguier 1 1 Mar. 11, 1975 APPARATUS FOR SEPARATING AND 2,842,122 7/1958 Butler 128/214 D IN BL 0D COMPONENT 2,848.995 8/1958 Ryannnm 128/214 D INJECT G 0 3,064,647 11/1962 Earl 128/272 x  Inventor: Leon Fernand Viguier, Samt-Prerre 3,110,308 11/1963 Bellamy, Jr 128/214 D de Mesage, France 3,187,750 6/1965 Tenczar, Jr. 1 128/272 3, 4 9 3 2 K l2 4 D  Assignee: Laboratories Medicoplast, Paris 6 8 6 3 Oremura (Seine), France  Filed: Oct. 6, 1972 Primary E.t arninerAldrich F. Medbery  Appl. No.: 295,687
57 ABSTRACT  Foreign Application Priority Data 1 OCT. l3, FI'ZIHCC Th device omprises a ystem of blood taking and decanting pockets interconnected by tubes, a storage U-S- r D, pocket the dimensions of correspond to [he [5 e amount f component to be injected a filter and in l l Field of Search l28/2l4 R1214 D1214 E, jection means in this storage pocket. The device is 128/272 214-2 particularly useful for separating by cryo-precipitation and for injecting into a patient the factor VIII used l l Referne$ Clted against haemophilia.
UNITED STATES PATENTS 2 2,702,034 2/1955 Walter 128/272 X 5 Claims, 3 Drawing Figures RHENIED NARI 1 I915 SHEET 1 0F 3 WNX FATEMEU 1 SWEET 2 OF 3 I 1 APPARATUS FOR SEPARATING AND INJECTING BLOOD COMPONENT vein and is stored in a first blood-taking pocket, where it undergoes a first treatment for initial separation. One of the components is then transferred to a second pocket in the system for a second separation treatment. One of the elements separated after this second treatment is passed to a final pocket where it is stored.
The element thus separated and intended to be injected into a patient is taken from this storage pocket by means of a hollow needle which is used to pierce the pocket. In the case of a blood component containing agglomerated elements, however, the device just described has disadvantages, since the agglomerated particles may obstruct the passage in the hollow needle or may enter the patients vein and create circulation problems. Incidents of this kind generally occur where the blood component has been separated by cryoprecipitation, since agglomerated elements still remain after thawing. In order to avoid such incidents, it is usual to dilute the component in a solution, especially an isotonic solution, before injecting it into the patient. This operation is usually carried out in an adjacent pocket into which the constituent taken is introduced by means of the hollow needle.
For the purpose of overcoming these disadvantages, it is also known to filter the blood before injecting it ,into the patient. A transfusion device of this kind is described in US. Pat. No. 2,702,034 filed on July 20, 1950. The filter chamber, usually of large capacity, is integrated into the means of transfusion and the dead volume of the latter therefore makes it impossible to use it for injecting small quantities.
Finally it is very difficult to remove the liquid from the storage pocket in a perfectly sterile manner in order to dilute it in the isotonic solution and inject it, while eliminating any riskof contamination of the element to be injected.
It is an object of this invention to provide a method and an apparatus to overcome these disadvantages and difficulties. The method in accordance with the present invention consists in the following steps:
the component is transferred in a sterile manner to a storage pocket connected to the system of blood-taking and decanting pockets, the pocket comprising an internal filter and having dimensions corresponding to the amount of component isolated;
the storage pocket is separated from the system of blood-taking and decanting pockets, and
the component is kept in the storage pocket until it is injected into the patients vein.
According to one embodiment of the invention, before the component just isolated is transferred to the storage pocket, it is mixed with a rinsing solution, especially an isotonic solution, which dilutes, in part, the agglomerated elements; this rinsing solution is contained in a pocket connected in a sealed and sterile manner to the system of blood-taking and decanting pockets.
The apparatus made in accordance with the present invention consists of a storage pocket containing a filter and having dimensions corresponding to the quantity of component isolated. The arrangement of the filter within the storage pocket is essential, since it produces adevice which is particularly compact and easy to use, in which dead volumes are greatly limited. This is essential if the quantities of component extracted from the blood are very small.
According to another embodiment of the invention, the storage pocket also comprises injection means adapted to the end of the filter. The purpose of this arrangement is to avoid contamination of the components in the storage pocket at the time of their injection, but this highly compact arrangement of the injection means also helps to greatly limit dead volumes.
According to another embodiment of the apparatus of the invention, the isotonic solution is kept, prior to use, in the storage pocket. Thus the storage pocket, which comprises a filter and injection means, contains a solution of the blood component already diluted and ready to be injected.
The invention will now be described in greater detail in conjunction with two forms of embodiment given by way of examples only, and illustrated in the attached drawings, wherein:
FIG. 1 shows a side elevational view of the device according to the invention;
FIG. 2 shows a side elevational view of the storage pocket, partly broken away and to an enlarged scale; and
FIG. 3 shows a side elevational view of another embodiment of the device according to the invention.
Illustrated in FIG. I is a device which comprises a first flexible pocket 1 made of transparent synthetic material. Opening into this pocket is the end of a flexible tube 3 made of weldable synthetic material, the other end thereof being integral with a hollow needle 4 protected by a sleeve 5.
Opening into pocket 1 is one end of a tube 8 made of weldable synthetic material, the other end of which is integral with one arm of a three-way union 9, the other two arms of which are connected respectively, through tubes 11 and 12, to flexible pockets 6 and 10. Pocket 10 is connected through a tube 13 to a storage pocket 14 made of two sheets of synthetic material welded together by their edges. Pocket 14 contains a filter 17 and injection means consisting, more particularly, of a tube 23 comprising an injection needle 15 protected by a cap 16.
Filter 17, seen in FIG. 2, consists of a piece of fabric in the form of a sleeve, one end thereof being held by the weld at the bottom of the pocket, while the other end accommodates a ferrule 18 to which it is attached by the weld joining together the two sheets of which the pocket is made.
In one particular configurationof the invention, ferrule 18 has an internal wall 19 intended to be pierced by a hollow needle 20 integral with a sleeve 21 connected to the injection needle by means of a tube 23.
A description will now be given of the method of using the device illustrated in FIGS. 1 and 2. Hollow needle 4 is inserted into the patients vein. After the blood has been collected in pocket 1, tube 3 is flattened in the vicinity of the pocket and its walls are welded together in order to close it off. The remainder of the tube, which is no longer in use, is then cut off.
such as cryo-precipitation, in order to separate an element"(such as factor VIII) used against haemophilia. After tube 8 has been closed off, the element of the blood to be separated is decanted, through tubes 11 and '12, into pocket which contains an isotonic solution to be mixed with the element. This mixture is then transferred to pocket 14 through tube 13.
Another way of using the present device consistsin passing the plasma contained in pocket 1 through tubes 8 and 12 into pocket 10, tube 11 being closed off, for example by means of a clamp. The component contained in the plasma (more particularly factor VIII which is used against haemophilia) is separated by cryo-precipitation in pocket 10. The unprecipitated fraction of the plasma is transferred to pocket 6 through tubes 11 and 12, after tube 8 has been closed off, for example with a clamp. The isotonic solution, which in this configuration of the invention, is contained in storage pocket 14, is transferred to pocket 10 where it is used to dilute the component separated by cryo-precipitation. Pocket 10 is carefully rinsed with this solution, and the mixture of isotonic solution and component is transferred to pocket 14 through tube 13.
Tube 13 is then flattened and welded and pocket 14 is then separated from pocket 10 by cutting the tube. The blood elements in pockets 1 and 6 are then retained for specific purposes, while the component in pocket 14 may be kept therein until it is-required for use.
At the time of use, sleeve 21 is pushed into ferrule 18 in a manner such that needle 20 pierces wall 19, after which needle 15 is inserted into the patients veinand the component in its isotonic solution is injected directly by rolling up pocket 14 in order to force the liquid through tube 23. The agglomerated elements cannot pass through filter 17 and they therefore remain in pocket 14. Dead volumes are limited to a minimum since pocket 14 is small in size and the useful volume thereof corresponds substantially to the volume of component placed in solution for injection into the patient; moreover, the filtermeans is integrated into the storage pocket. A device of this kind also prevents contamination and ensures storage and injection under completely sterile conditions.
FIG. 3 shows blood-taking pocket 1 with its means for taking blood, namely hollow needle 4 protected by cap 5. This pocket is connected, through tube 32, to a second pocket 30 which is connected in turn, through a tube 33, to a third pocket 31 and, through a tube 34, to a storage pocket 14. This latter pocket comprises a filter 17 integral with a ferrule 18 as described in connection with FIG. 2, the ferrule being integral with a sterile access port 35, and the end of the ferrule being adaptable to the injection means.
The method of using this device to isolate and inject a component containing agglomerated elements will now be described.
The blood taken from the subjects vein is subjected to initial fractionation in pocket 1, more particularly by .centrifuging. The plasma is transferred, through tube 32, to pocket 30, after which the tube is heat sealed or welded and cut off. The plasma in pocket 30 is again fractionated, more particularly by cryo-precipitation, in order to isolate those components which are present in very small quantities in human blood and which possess therapeutical properties. After being thawed out, the liquid fraction of the plasma is transferred, through tube 33, to pocket 31, during which transfer tube 34 is closed off, for example with a clamp. After tube 32 has been closed off, the rinsing solution in storage pocket 14 ispassed, through tube 34, into pocket 30 which contains the component separated by cryoprecipitation. The mixture thus obtained is again transferred to pocket 14, where it is retained after tube 34 has been welded and cut off. During this latter operation, sterile air trapped in pocket 14 is evacuated through tube 34, so that pocket 14 is completely filled. In order to inject the solution containing the component into the patients vein, a catheter containing a tube of very small cross section is connected to pocket 14. This catheter is fitted to ferrule 18 in access port 35 after the port has been opened under sterile conditions. The liquid is then injected by compressing pocket 14. The agglomerated elements are retained in pocket 14 by filter 17. Moreover, there is no risk of introducing air into the patients vein, since care is taken to remove the air from pocket 14 before it is sealed. Moreover, the dead volume of the injection tube is as small as possible, and almost the entire amount of the solution contained in the storage pocket is injected. Finally, the injection means may be disconnected from access port 35 in pocket 14 and connected to a new pocket. It is thus possible to inject into the patients vein as many doses as may be required, with no fear of the fine injection tube becoming blocked.
It is to be understood thatthe invention is not restricted in interpretation except by the scope of the following claims.
1. In an apparatus for sampling and fractionating blood components including a plurality of sampling and fractionating pockets interconnected by tubing, a means for sequentially isolating, storing and intravenously injecting into a patient a blood component present in small amounts in the blood and liable to contain agglomerated elements,
said means comprising:
a distinct storage pocket for said component,
the inlet of said storage pocket being connected by sectionable tubing to said plurality of sampling and fractionating pockets, the outlet of said storage pocket being sealed and having means for being equipped with injection means; I a filter means for'preventing the injection of the agglomerated elements incorporated inside said storage pocket between said inlet and said outlet; said storage pocket being of dimensions substantially corresponding to the quantity of the component separated.
2. An apparatus according to claim 1, wherin said filter means consists of a tubular length of a filter fabric in the form of a sleeve running longitudinally inside said storage pocket,
one end of said sleeve being held closed at the bottom of said storage pocket,
the other end surrounding an outlet ferrule, said other end and said ferrule being held at the top of said storage pocket. J
other end and said ferrule being held between said sheets by the weld at the top of said storage pocket.
4. An apparatus according to claim 2, wherein said injection means is integral with said outlet ferrule.
5. An apparatus according to claim 2, wherein said outlet ferrule is further surrounded by a sterile access port, said injection means being adaptable to said access port.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US2702034 *||Jul 20, 1950||Feb 15, 1955||Fenwal Inc||Apparatus for collecting, storing, and dispensing whole blood|
|US2842122 *||Aug 2, 1955||Jul 8, 1958||Cutter Lab||Filter|
|US2848995 *||Sep 11, 1953||Aug 26, 1958||Abbott Lab||Transfusion apparatus|
|US3064647 *||Jun 13, 1957||Nov 20, 1962||Baxter Laboratories Inc||Blood component separation method and apparatus|
|US3110308 *||Oct 20, 1960||Nov 12, 1963||Baxter Laboratories Inc||Parenteral fluid administration equiment|
|US3187750 *||Jan 15, 1963||Jun 8, 1965||Baxter Laboratories Inc||Multiple bag blood storage unit|
|US3648693 *||May 26, 1970||Mar 14, 1972||Jintan Terumo Co||Bag apparatus for transfusion of blood or fluid involving heat shrinkable tube means|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US3986506 *||Sep 3, 1974||Oct 19, 1976||Baxter Travenol Laboratories, Inc.||Apparatus for separation of cryoprecipitate from blood plasma and method|
|US4474568 *||Jan 21, 1982||Oct 2, 1984||Haemonetics Corporation||Multipurpose component container and anticoagulant bag|
|US4680025 *||Nov 27, 1984||Jul 14, 1987||Baxter Travenol Laboratories, Inc.||Blood component collection systems and methods|
|US4915847 *||Aug 4, 1987||Apr 10, 1990||Baxter International Inc.||Cryoglobulin separation|
|US4917804 *||Oct 31, 1986||Apr 17, 1990||Baxter International Inc.||Method and vessel for separation of cryoglobin|
|US4985153 *||Jun 23, 1989||Jan 15, 1991||Asahi Medical Co., Ltd.||Method for separating blood into blood components, and blood components separator unit|
|US4994039 *||Feb 6, 1987||Feb 19, 1991||Mattson Philip D||Apparatus and method for patients from a single donor or a restricted group of donors|
|US5030215 *||Jan 3, 1990||Jul 9, 1991||Cryolife, Inc.||Preparation of fibrinogen/factor XIII precipitate|
|US5071570 *||Nov 19, 1990||Dec 10, 1991||Terumo Corporation||Method for separation of blood components and apparatus thereof|
|US5141645 *||Jun 5, 1991||Aug 25, 1992||Terumo Corporation||Apparatus for separation of blood components|
|US5167656 *||Jan 22, 1991||Dec 1, 1992||Baxter International Inc.||Blood container having lay-flat sample reservoir|
|US5300060 *||Oct 7, 1991||Apr 5, 1994||Miles Inc.||Blood bag system for separation and isolation of neocytes and gerocytes|
|US5318782 *||Feb 25, 1993||Jun 7, 1994||Weis Fogh Ulla S||Method for preparing tissue repair promoting substances|
|US5399268 *||Jul 6, 1994||Mar 21, 1995||Pall Corporation||Method for processing blood for human transfusion|
|US5445736 *||Apr 25, 1994||Aug 29, 1995||Pall Corporation||Device and filter element for processing blood for human transfusion|
|US5462716 *||Nov 10, 1992||Oct 31, 1995||Holm; Niels E.||Container for receiving and separating a fluid, preferably blood plasma, into its ingredients|
|US5480378 *||Aug 24, 1994||Jan 2, 1996||Weis-Fogh; Ulla||Apparatus for preparing a concentrate of coagulation factors from a blood sample|
|US5543060 *||Jun 6, 1995||Aug 6, 1996||Pall Corporation||Method for processing blood for human transfusion|
|US5578326 *||May 12, 1995||Nov 26, 1996||E. R. Squibb & Sons, Inc.||Method and an apparatus for preparing tissue repair promoting substances|
|US5580465 *||Dec 3, 1993||Dec 3, 1996||Pall Corporation||Method for preparing platelets|
|US5658533 *||Jun 6, 1995||Aug 19, 1997||E.R. Squibb & Sons, Inc.||Container for receiving and separating a fluid into its ingredients|
|US5674458 *||Jun 6, 1995||Oct 7, 1997||E. R. Squibb & Sons, Inc.||Container for receiving and separating a fluid into its ingredients|
|US5746979 *||Jun 6, 1995||May 5, 1998||F. R, Squibb & Sons, Inc.||Method for receiving and separating a fluid into its ingredients|
|US6284285||Dec 29, 1992||Sep 4, 2001||E. R. Squibb & Sons, Inc.||Tissue repair promoting composition|
|US6994790||Feb 3, 2003||Feb 7, 2006||Gambro, Inc.||Whole blood collection and processing method|
|US7025877||Jun 3, 1999||Apr 11, 2006||Baxter International Inc.||Processing set for processing and treating a biological fluid|
|US7105093||Oct 8, 2002||Sep 12, 2006||Baxter International Inc.||Processing set and methods for processing and treating a biological fluid|
|US7425304||Feb 13, 2006||Sep 16, 2008||Fenwal, Inc.||Processing set and methods for processing and treating a biological fluid|
|US7445756||Oct 11, 2002||Nov 4, 2008||Fenwal, Inc.||Fluid processing sets and organizers for the same|
|US7601268||May 27, 2003||Oct 13, 2009||Haemonetics Corporation||Continuous blood filtration and method of use|
|US8222027 *||Dec 17, 2008||Jul 17, 2012||Cook General Biotechnolgy, LLC||Systems and methods for cryopreservation of cells|
|US8709797||Feb 24, 2010||Apr 29, 2014||Cook General Biotechnology Llc||Systems and methods for cryopreservation of cells|
|US8936905||Jul 16, 2012||Jan 20, 2015||Cook General Biotechnology Llc||Systems and methods for cryopreservation of cells|
|US20030146162 *||Oct 11, 2002||Aug 7, 2003||Metzel Peyton S.||Fluid processing sets and organizers for the same|
|US20030146170 *||Feb 3, 2003||Aug 7, 2003||Frank Corbin||Whole blood collection and processing method|
|US20040238444 *||May 27, 2003||Dec 2, 2004||Michael Ragusa||Continuous blood filtration and method of use|
|US20050274673 *||Jun 24, 2005||Dec 15, 2005||Gambro, Inc||Whole blood collection and processing method|
|US20060197031 *||Feb 13, 2006||Sep 7, 2006||De Gheldere Serge||Processing set and methods for processing and treating a biological fluid|
|US20090148934 *||Dec 17, 2008||Jun 11, 2009||General Biotechnology, Llc||Systems and Methods for Cryopreservation of Cells|
|US20100196873 *||Aug 5, 2010||Vialco, Llc||Systems and Methods for Cryopreservation of Cells|
|US20120171658 *||May 27, 2010||Jul 5, 2012||Justus-Liebig-Universitšt Giessen||Device and procedure for the manufacture of blood products|
|DE2845365A1 *||Oct 18, 1978||Apr 19, 1979||Baxter Travenol Lab||Pressure monitor circulation flow arrangement - is single-use equipment with at least two leads for collection of blood components|
|EP0175274A2 *||Sep 11, 1985||Mar 26, 1986||TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION||Method of separation of blood components|
|WO1984000905A1 *||Aug 17, 1983||Mar 15, 1984||Baxter Travenol Lab||Blood component collection systems and methods|
|WO1992012684A1 *||Jan 10, 1992||Aug 6, 1992||Baxter International Inc.||Blood container having lay-flat sample reservoir|
|WO2010136535A1 *||May 27, 2010||Dec 2, 2010||Justus-Liebig-Universitšt Giessen||Device and method for producing blood products|
|U.S. Classification||604/406, 604/410|
|International Classification||A61M39/00, A61M39/22, A61M1/02|
|Cooperative Classification||A61M2202/0454, A61M39/221, A61M1/0209, A61M2205/7545, A61M1/02|
|European Classification||A61M1/02B, A61M1/02, A61M39/22C|